Indication
Immune Activation
1 clinical trial
3 products
Clinical trial
Effects of Mu-opiate Receptor Engagement on Microbial Translocation and Residual Immune Activation in HIV-infected, ART Suppressed Opioid Use Disorder Patients Initiating Medication-assisted TreatmentStatus: Recruiting, Estimated PCD: 2024-06-30
Product
MethadoneProduct
Buprenorphine/naloxoneProduct
XR-Naltrexone